Today, a link on LinuxToday.net brought me to an OSCON video https://www.youtube.com/watch?v=eQGWrdgu_fE
by Dana Lewis and her middleware https://github.com/openaps/openaps to assemble a bunch of off-the shelf components to establish a feedback loop to control blood sugar levels. Their philosophy is that to comply with FDA regulations the device should not be sold, it is up to the individuals and their parents to establish it all, on their very own responsibility this means. I am tempted to just go and package it. At the same time, any stupid problem with anything (not necessarily within OpenAPS itself) could have severe consequences, which includes death or brain damage. On the other hand, especially the continuous integration checking of Debian is helpful to spot some library inconsistencies upfront. There is also the possibility to only offer the package in unstable (with an artificial RC bug to prevent a migration to testing), so we could for instance offer the continuous integration only and motivate the development of respective tests by the community and see how things develop. So, how do you feel? Should we duck or cover it? Best, Steffen
